Tag: Big Pharma

From the Center for Health Journalism: Due to drug safety scandals and rising drug prices, pharmaceutical representatives are increasingly being criticized by physicians, medical schools, and...

From Medical Xpress: According to Greece's justice minister Stavros Kontonis, it is likely that the pharmaceutical company Novartis has bribed thousands of medical professionals and state officials...

From The Onion: "Visibly trembling as he wiped beads of perspiration from his forehead, Arcelis Pharmaceuticals CEO Paul Corrier told reporters Wednesday that he could...

From STAT: A new documentary, "The Painful Truth," chronicles the plight of several patients struggling to find treatment for their chronic pain, suggesting that physicians...

From VTDigger: A new bill has been introduced in Vermont that would scale back the state's law banning pharmaceutical companies from providing certain gifts to health care...

From NBC: A new patients' rights advocacy group called Patients for Affordable Drugs is fighting for lower drug prices. Because the group does not receive funding...

From Nature: FDA regulation plays a major role in the functioning of our economy. Trump's plans to deregulate the FDA will not only put...

From Reuters: President Trump has selected Dr. Scott Gottlieb, a conservative health policy expert with deep ties to the pharmaceutical industry, to lead the FDA. Article...

From MinnPost: Two recent articles have exposed some of the potentially dangerous effects of alternative treatments including homeopathy and acupuncture, as well as corruption in...

From The New York Times: A new study has found that more than 80 percent of the nation's patient advocacy groups accept funding from drug...

From The Province: Mothers alleging that taking Paxil during pregnancy caused heart problems for their children have reached a settlement of $6.2-million with GlaxoSmithKline U.K. Article...

From ProPublica: The pharmaceutical company has deployed a potent new ally to justify skyrocketing drug prices. Precision Health Economics, a firm comprised of leading economists and...

An issue that often crops up is the question of whether treatment would be safer if given by specialists (partialists) rather than general practitioners (generalists). This could not be more wrong. In most areas of medicine, nobody looks or listens anymore, least of all in psychiatry.

From the Center for Health Journalism: President Trump's plans to speed up the process of FDA drug approvals, in combination with the increase of off-label...

From AlterNet: The increasing pace at which the FDA is approving new drugs can lead to significant risks to patient safety. Drugs that once would have...

Active Minds allows college students to start conversations on some of the most difficult struggles we face in life, but I urge the organization to lead the conversation away from bad science and towards the common struggles that we endure as human beings.

To illustrate the dangers of Trump's plans to deregulate the FDA, Susan Perry from MinnPost provides a cautionary tale about Tarceva, a drug approved by the...

From STAT: President Trump plans to decrease regulations on the Food and Drug Administration. Medical experts and healthcare professionals have expressed concerns that this could expose...

"Prozac is what I call the Big Bang of pharmaceutical naming. It came out of nowhere, it means absolutely nothing, and it really just...

“At a time when Americans pay, by far, the highest prices in the world for prescription drugs, this bill provides absolutely no relief for...

Martha Rosenberg, for AlterNet: “Pharma may be becoming one of the public's most reviled sectors but the U.S. government is in the process of...

“The executive who once ran the specialty pharmacy at the heart of the Valeant Pharmaceutical accounting scandal was arrested Thursday morning, along with a...

For STAT, Rebecca Robbins reports that we’ll soon see drug ads – “both overt and stealthy” – on Facebook and other social media outlets. Article...

STAT reports on the continuing struggles of state governments to reign in pharmaceutical costs in the wake of failed efforts in California.

TIME magazine covers a new report suggesting that many medical reviewers who work for the FDA go on to work for the drug companies they...